Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 4, p. 151
- Publication type:
- Article
Works matching IS 21641153 AND DT 2017 AND VI 7
Results: 24
1
2
Current Treatment Options for Metastatic Renal-Cell Carcinoma: Review of the Literature.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 4, p. 144
- By:
- Publication type:
- Article
3
Hypertension Caused by VEGF-Signaling Pathway Inhibitors.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 4, p. 141
- By:
- Publication type:
- Article
4
Successful Treatment of Chronic Myeloid Leukemia with Low-Dose Nilotinib.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 4, p. 139
- By:
- Publication type:
- Article
5
Evaluation of the Duration of Oral Chemotherapies Use at a Community Cancer Center.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 4, p. 134
- By:
- Publication type:
- Article
6
Enzalutamide in the Treatment of Patients with Metastatic Castrate-Resistant Prostate Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 3, p. 114
- By:
- Publication type:
- Article
7
Pain Assessment Practices in Patients with Cancer Admitted to the Oncology Floor.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 3, p. 109
- By:
- Publication type:
- Article
8
Retrospective Analysis of Probiotic Effectiveness in Patients with Acute Myeloid Leukemia or Patients Undergoing Transplant Who Are Receiving Chemotherapy.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 3, p. 103
- By:
- Publication type:
- Article
9
Comparing Oral Chemotherapy Safe Prescribing Practices in an Academic Health System: A Retrospective Analysis.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 2, p. 83
- By:
- Publication type:
- Article
10
A Taxing Consequence: Taxane Acute Pain Syndrome.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 2, p. 80
- By:
- Publication type:
- Article
11
Florida Pharmacy Students' Perspectives on Careers in Oncology.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 2, p. 69
- By:
- Publication type:
- Article
12
Identified Complications of Extended International Travel for Patients Receiving Oral Anticancer Drugs.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 2, p. 66
- By:
- Publication type:
- Article
13
Venclexta (Venetoclax) First BCL-2 Inhibitor Approved for High-Risk Relapsed Chronic Lymphocytic Leukemia.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, p. 53
- By:
- Publication type:
- Article
14
Tecentriq (Atezolizumab), PD-L1 Inhibitor, Approved for Advanced Bladder Cancer and for Relapsed Non-Small-Cell Lung Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, p. 49
- By:
- Publication type:
- Article
15
Rubraca (Rucaparib) Second PARP Inhibitor Approved for Patients with Advanced, BRCA-Positive Ovarian Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, p. 39
- By:
- Publication type:
- Article
16
Revlimid (Lenalidomide) Receives New Indication for Multiple Myeloma as Maintenance Therapy After Transplantation.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, p. 36
- By:
- Publication type:
- Article
17
Lartruvo (Olaratumab) a Novel First- Line Treatment Approved for Patients with Advanced Soft-Tissue Sarcoma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, p. 33
- By:
- Publication type:
- Article
18
Imbruvica (Ibrutinib) Now FDA Approved as First-Line Treatment for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, p. 30
- By:
- Publication type:
- Article
19
FDA Approvals of Brand-Name Prescription Drugs in 2016.
- Published in:
- 2017
- Publication type:
- Product Review
20
Welcome to the Second Annual Oncology Pharmacy Guide to New FDA Approvals.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, p. 10
- Publication type:
- Article
21
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 1, p. 51
- By:
- Publication type:
- Article
22
Novel Systemic Therapies for Advanced Non–Small-Cell Lung Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 1, p. 34
- By:
- Publication type:
- Article
23
EGFR Inhibitor–Associated Papulopustular Rash.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 1, p. 27
- By:
- Publication type:
- Article
24
Clostridium Difficile Infection Retreatment Based on Initial Therapy in Patients with Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2017, v. 7, n. 1, p. 18
- By:
- Publication type:
- Article